GeneralBullishMIT Technology Review · 12h ago7/10
📰
David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition
Longevity scientist David Sinclair plans to launch human trials of an oral "reprogramming" drug designed to reverse aging, testing the treatment through a $101 million XPrize competition. This represents a significant shift from theoretical research to clinical validation of cellular rejuvenation technology.